Stock 531015 VENMAX DRUGS AND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Venmax Drugs and Pharmaceuticals Limited

Equities

531015

INE154G01022

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2019
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018
CI
Venmax Drugs and Pharmaceuticals Ltd Reports Earnings Results for the Second Quarter Ended September 30, 2018
CI
Venmax Drugs and Pharmaceuticals Limited Announces Unaudited Earnings Results for the First Quarter Ended June 30, 2018
CI
Venmax Drugs & Pharmaceuticals Ltd. Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2018
CI
Venmax Drugs and Pharmaceuticals Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
CI
Venmax Drugs and Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 531015 Stock
  4. News Venmax Drugs and Pharmaceuticals Limited
  5. Highlights